Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
03/2002
03/21/2002US20020035109 Benzamidine derivatives and their use as anti-coagulants
03/21/2002CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists
03/20/2002EP1188779A1 Process for preparing a storage-stable rheologically active urea-urethane solution with broad compatibility
03/20/2002EP1188710A2 Process for the integrated preparation of ammonia and urea
03/20/2002CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/20/2002CN1341095A Amide compounds for potentiation of cholinergic activity
03/14/2002US20020032347 Guanidine and acylurea derivatives as anticancer, antishock, and antiinflammatory agents
03/14/2002US20020032223 Benzamidine derivatives and their use as anti-coagulants
03/14/2002US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen
03/13/2002CN1080720C 噻唑衍生物 Thiazole derivatives
03/07/2002WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
03/07/2002WO2002017712A2 Disubstituted benzenes as insecticides
03/07/2002WO2001070684A3 Peptidomimetic ligands for cellular receptors and ion channels
03/07/2002US20020028949 Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one
03/07/2002US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis
03/07/2002US20020028851 Guanylhydrazones and their use to treat inflammatory conditions
03/07/2002US20020028836 Potassium channel openers
03/07/2002US20020028799 Using protease and phospodiesterase inhibitor
03/07/2002DE10039837A1 Preparing urea-urethane solution, useful as thixotropic agent for coating compositions, by reacting diamine with two different monoisocyanate adducts
03/07/2002CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
03/06/2002EP1183231A1 Cytofectin dimers and methods of use thereof
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
03/06/2002EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof
03/06/2002CN1338453A Preparation of wide compatible, stable and rheologic activating urethane solution
03/05/2002US6353111 Which increase insulin secretion in the treatment of type ii diabetes; 2,3-di-substituted trans olefinic n-heteroaromatic or urido propionamides: the substitution at the 2-position being a substituted phenyl group and at the 3-position a
03/05/2002US6353099 Substituted ureas as cell adhesion inhibitors
03/05/2002US6353023 Aromatic compounds with amide groups
03/05/2002US6352977 Substituted β-alanines
02/2002
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/28/2002US20020025965 Antiserotonine agents
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/27/2002EP1181271A2 Naphthalene ureas as glucose uptake enhancers
02/27/2002EP0817770B1 Nonpeptides as tachykinin antagonists
02/27/2002CN1337941A Amide derivatives
02/27/2002CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound
02/27/2002CN1079790C Process and plant for production of urea with high conversion yield and low energy consumption
02/26/2002US6350746 Benzamidine derivatives and their use as anti-coagulants
02/21/2002WO2002014267A1 Novel aminocyclohexane derivatives
02/21/2002WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof
02/21/2002WO2002014264A2 (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
02/21/2002WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic
02/21/2002US20020022747 For cancer theapy
02/21/2002US20020022727 Method for producing ar(alk)yluraciles, novel corresponding intermediate products and method for producing said intermediate products
02/20/2002CN1079393C Aminophenol derivatives and their use in cosmetics
02/14/2002WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides
02/14/2002WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
02/14/2002WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
02/14/2002US20020019393 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
02/14/2002US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties
02/14/2002US20020019374 Salicylohydrazide derivatives, processes and intermediates for their preparation, compositions comprising them, and their use
02/14/2002DE10038007A1 Neue Amino-und Amido-Diphenylether für Arzneimittel New amino and amido diphenyl ether for drugs
02/14/2002CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides
02/14/2002CA2416906A1 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a]imidazol-2-one
02/14/2002CA2415467A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
02/13/2002EP1179032A1 Nucleators for crystallizable thermoplastic polymers
02/13/2002EP1178958A2 N-cyanomethyl amides as protease inhibitors
02/13/2002EP1178797A1 Inhibitors of impdh enzyme
02/13/2002CN1335302A Biuret polyisocyanic acid ester and its producing process
02/07/2002WO2001030333A3 Tissue factor antagonists and methods of use thereof
02/07/2002US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/07/2002US20020016350 Useful in treatment of diseases or conditions associated with erythropoietin receptor
02/07/2002US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production.
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1177200A1 Ligands for metabotropic glutamate receptors
02/06/2002EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
02/06/2002EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/06/2002EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/06/2002CN1334833A Coating agents which can be hardened by addition of isocyanate groups as well as by radiation-induced addition of activated c-c double covalent bonds
02/06/2002CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/05/2002US6344570 Substituted urea derivatives as cell adhesion inhibitors
02/05/2002US6344562 Thiazole derivatives
02/05/2002US6344465 Inhibitors of IMPDH enzyme
01/2002
01/31/2002WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
01/31/2002WO2002008174A1 Phenylethylamine derivatives and their use in the treatment of melanoma
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/31/2002WO2001014328A3 Substituted ureas as cell adhesion inhibitors
01/31/2002US20020013497 Alkylation, blocking
01/31/2002US20020013256 Novel inhibitors of formation of advanced glycation endproducts (AGES)
01/30/2002EP1175392A1 Contrast media
01/30/2002CN1078587C Urea and urethane monomers for contact lens materials
01/29/2002US6342632 Process and plant for the production of urea with high conversion yield and low energy consumption
01/24/2002WO2002006189A2 Aniline derivatives
01/24/2002US20020010360 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1- methanol
01/24/2002US20020010316 Thiazole derivatives
01/24/2002US20020010281 Curable electron donor compounds
01/23/2002EP1173468A1 Integrin receptor antagonists
01/23/2002EP1173415A1 Diphenylurea derivatives
01/23/2002EP0739903B1 Carbamoylmethylurea derivative
01/23/2002CN1332725A Thiourea inhibitors of herpes viruses
01/22/2002US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/22/2002US6340451 Method for the simultaneous modernization of a plant for ammonia production and a plant for urea production
01/17/2002WO2002004407A2 7-substituted tetracycline compounds
01/17/2002WO2002004406A2 9-substituted minocycline compounds
01/17/2002WO2002003995A2 Treatment of male sexual dysfunction
01/17/2002US20020007045 For inhibiting the aggregation of blood platelets; 3-(4-Aminomethyl-phenyl)-1-(2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl)-1 -isopropyl-urea for example
01/17/2002US20020006957 Method for the synthesis of compounds of formula I and their uses thereof
01/17/2002CA2414112A1 Treatment of male sexual dysfunction
01/16/2002EP1172358A1 N-substituted-n'-substituted urea derivative and medicinal compositions containing the same
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 99